drugset / Trial / NCT07532135
Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer
RandomizedParallel-groupTriple-blindOther
Summary
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2026-09-01
- Completion
- 2026-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mulberry leaf extract | Unknown | 12 mg | — |